Arthritis, Rheumatoid
Immunology·MeSH: Arthritis, Rheumatoid
Prevalence
239.6 / 100K
Incidence
13.3 / 100K/yr
4 drugs in development·4 companies·7 clinical trials
Drug Pipeline by Phase
Phase 2(2)
Phase 1(1)
| Drug | Company |
|---|---|
| ly3009104 | ELI LILLY & Co (LLY) |
Phase 4(1)
| Drug | Company |
|---|---|
| bms-986528 | BRISTOL MYERS SQUIBB CO (BMY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Arthritis, Rheumatoid?
BioSniper tracks 4 drugs in development for Arthritis, Rheumatoid across 4 companies.
How many clinical trials target Arthritis, Rheumatoid?
There are 7 clinical trials targeting Arthritis, Rheumatoid tracked by BioSniper.
What is the prevalence of Arthritis, Rheumatoid?
The estimated prevalence of Arthritis, Rheumatoid is approximately 239.6 per 100,000 population.
Deep-dive into Arthritis, Rheumatoid
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis